Noemi Atucha

Dr. Noemi Atucha

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
FVFélix Vargas
Félix Vargas
PRPaola Romecín
Paola Romecín
AGAna Isabel García-Guillén
Ana Isabel García-Guillén
RWRosemary Wangesteen
Rosemary Wangesteen
PVPablo Vargas-Tendero
Pablo Vargas-Tendero
Joaquin Garcia-EstañJoaquin Garcia-Estañ
Joaquin Garcia-Estañ
This review summarizes the latest advances in knowledge on the effects of flavonoids on renal function in health and disease. Flavonoids have antihypertensive, antidiabetic, and antiinflammatory effects, among other therapeutic activities. Many of them also exert renoprotective actions that may be of interest in diseases such as glomerulonephritis, diabetic nephropathy, and chemically-induced kidney insufficiency. They affect several renal factors that promote diuresis and natriuresis, which may contribute to their well-known antihypertensive effect. Flavonoids prevent or attenuate the renal injury associated with arterial hypertension, both by decreasing blood pressure and by acting directly on the renal parenchyma. These outcomes derive from their interference with multiple signaling pathways known to produce renal injury and are independent of their blood pressure-lowering effects. Oral administration of flavonoids prevents or ameliorates adverse effects on the kidney of elevated fructose consumption, high fat diet, and types I and 2 diabetes. These compounds attenuate the hyperglycemia-disrupted renal endothelial barrier function, urinary microalbumin excretion, and glomerular hyperfiltration that results from a reduction of podocyte injury, a determinant factor for albuminuria in diabetic nephropathy. Several flavonoids have shown renal protective effects against many nephrotoxic agents that frequently cause acute kidney injury (AKI) or chronic kidney disease (CKD), such as LPS, gentamycin, alcohol, nicotine, lead or cadmium. Flavonoids also improve cisplatin- or methotrexate-induced renal damage, demonstrating important actions in chemotherapy, anticancer and renoprotective effects. A beneficial prophylactic effect of flavonoids has been also observed against AKI induced by surgical procedures such as ischemia/reperfusion (I/R) or cardiopulmonary bypass. In several murine models of CKD, impaired kidney function was significantly improved by the administration of flavonoids from different sources, alone or in combination with stem cells. In humans, cocoa flavanols were found to have vasculoprotective effects in patients on hemodialysis. Moreover, flavonoids develop antitumor activity against renal carcinoma cells with no toxic effects on normal cells, suggesting a potential therapeutic role in patients with renal carcinoma.

8 April 2011 in International Endodontic Journal
Verified
Journal Article
Closed access
PDF file
FRF. J. Rodríguez-Lozano
F. J. Rodríguez-Lozano
CBC. Bueno
C. Bueno
CIC. L. Insausti
C. L. Insausti
LMLuis Meseguer-Olmo
Luis Meseguer-Olmo
MRM. C. Ramírez
M. C. Ramírez
Jose M MoraledaJose M Moraleda
Jose M Moraleda

1 August 2014 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
Francisco Javier Rodríguez-LozanoFrancisco Javier Rodríguez-Lozano
Francisco Javier Rodríguez-Lozano
DGDavid García-Bernal
David García-Bernal
SASalvador D. Aznar-Cervantes
Salvador D. Aznar-Cervantes
MRM. A. Ros-Roca
M. A. Ros-Roca
MAM. C. Algueró
M. C. Algueró
JCJ. L. Cenis
J. L. Cenis

27 April 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JMJosé E. Millán-Rivero
José E. Millán-Rivero
CMCARLOS MARTINEZ
CARLOS MARTINEZ
PDPaola Alejandra Romecin Duran
Paola Alejandra Romecin Duran
SASalvador D. Aznar-Cervantes
Salvador D. Aznar-Cervantes
MCMarina Carpes-Ruiz
Marina Carpes-Ruiz
DGDavid García-Bernal
David García-Bernal
The treatment of extensive and/or chronic skin wounds is a widespread and costly public health problem. Mesenchymal stem cells (MSCs) have been proposed as a potential cell therapy for inducing wound healing in different clinical settings, alone or in combination with biosynthetic scaffolds. Among them, silk fibroin (SF) seeded with MSCs has been shown to have increased efficacy in skin wound healing experimental models. In this report, we investigated the wound healing effects of electrospun SF scaffolds cellularized with human Wharton’s jelly MSCs (Wj-MSCs-SF) using a murine excisional wound splinting model. Immunohistopathological examination after transplant confirmed the presence of infiltrated human fibroblast-like CD90-positive cells in the dermis of the Wj-MSCs-SF-treated group, yielding neoangiogenesis, decreased inflammatory infiltrate and myofibroblast proliferation, less collagen matrix production, and complete epidermal regeneration. These findings indicate that Wj-MSCs transplanted in the wound bed on a silk fibroin scaffold contribute to the generation of a well-organized and vascularized granulation tissue, enhance reepithelization of the wound, and reduce the formation of fibrotic scar tissue, highlighting the potential therapeutic effects of Wj-MSC-based tissue engineering approaches to non-healing wound treatment.

1 January 2012 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Francisco Javier Rodríguez-LozanoFrancisco Javier Rodríguez-Lozano
Francisco Javier Rodríguez-Lozano
CICl. Insausti
Cl. Insausti
FIF. Iniesta
F. Iniesta
MBMiguel Blanquer Blanquer
Miguel Blanquer Blanquer
MRMc. Ramírez
Mc. Ramírez
JMJm. Moraleda
Jm. Moraleda
In the last decade, tissue engineering is a field that has been suffering an enormous expansion in the regenerative medicine and dentistry. The use of cells as mesenchymal dental stem cells of easy access for dentist and oral surgeon, immunosuppressive properties, high proliferation and capacity to differentiate into odontoblasts, cementoblasts, osteoblasts and other cells implicated in the teeth, suppose a good perspective of future in the clinical dentistry. However, is necessary advance in the known of growth factors and signalling molecules implicated in tooth development and regeneration of different structures of teeth. Furthermore, these cells need a fabulous scaffold that facility their integration, differentiation, matrix synthesis and promote multiple specific interactions between cells. In this review, we give a brief description of tooth development and anatomy, definition and classification of stem cells, with special attention of mesenchymal stem cells, commonly used in the cellular therapy for their trasdifferentiation ability, non ethical problems and acceptable results in preliminary clinical trials. In terms of tissue engineering, we provide an overview of different types of mesenchymal stem cells that have been isolated from teeth, including dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHEDs), periodontal ligament stem cells (PDLSCs), dental follicle progenitor stem cells (DFPCs), and stem cells from apical papilla (SCAPs), growth factors implicated in regeneration teeth and types of scaffolds for dental tissue regeneration.

1 December 1996 in Gastroenterology
Verified
Journal Article
Closed access
NANoemi Atucha
Noemi Atucha
VSV Shah
V Shah
GGG Garcia-Cardena
G Garcia-Cardena
WSWe Sessa
We Sessa
RGRj Groszmann
Rj Groszmann